A recent study details the use of a small molecule to slow the growth of a specific genus of bacteria in the gut microbiome. There may be implications for treatment of Type 1 diabetes.
Articles by Hannah Halusker
In an extension of research published a month ago in Nature Methods, a novel hybrid approach performed by researchers from Clemson University’s department of physics and astronomy and Stony Brook University has revealed a 3-D structure of a protein fragment that could serve as a drug target in treating stroke patients. The protein called “postsynaptic density protein of 95 kDa (PSD-95)” is […]